Amicus Therapeutics (FOLD) Misses Q4 EPS by 6c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/29/2026

1. NOW
2. MSFT
3. GOOGL
4. FTNT
5. EBAY
6. TENB
7. CMG
8. KLAC
9. BIIB
10. ETSY

Go back to Amicus Therapeutics (FOLD) Misses Q4 EPS by 6c

Amicus Therapeutics Announces Full-Year 2014 Financial Results and Corporate Updates

March 3, 2015 4:01 PM EST

MAA Submission for Migalastat Monotherapy for Fabry Disease on Track for Mid-2015 FDA Meeting Scheduled in 1Q15 to Discuss U.S. Pathway

Next-Generation Pompe ERT Set to Enter Clinic in 2H15

CRANBURY, N.J., March 3, 2015 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a biopharmaceutical company at the forefront of therapies for rare and orphan diseases, today announced financial results for the full-year ended December 31, 2014. The Company also provided program updates and reiterated full-year 2015 net cash spend... More